Tian Yu

Dr. Tian Yu

Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2022 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HSHai Shang
Hai Shang
JGJing Guo
Jing Guo
PWPengtao Wang
Pengtao Wang
LLLingyu Li
Lingyu Li
TYTian Yu
Tian Yu
ZZZhong-Mei Zou
Zhong-Mei Zou

12 April 2018 in Toxins
Verified
Journal Article
Open access
PDF file
SWShan Wang
Shan Wang
MWMin Wang
Min Wang
TYTian Yu
Tian Yu
XSXiao Sun
Xiao Sun
GSGuibo Sun
Guibo Sun
XSXiaobo Sun
Xiaobo Sun
Drug-induced liver injury is one of the main causes of drug non-approval and drug withdrawal by the Food and Drug Administration (FDA). Bavachinin (BVC) is a natural product derived from the fruit of the traditional Chinese herb Fructus Psoraleae (FP). There have been reports of acute liver injury following the administration of FP and its related proprietary medicines. To explore BVC hepatotoxicity and its mechanisms, we used the HepaRG cell line. In our recent research, we showed that BVC induces HepaRG cell death, mainly via BVC-induced oxidative damage. The formation of ROS is closely related to the activation of the stress-activated kinases, JNK and p38, while SP600125 (SP, JNK inhibitor) and SB203580 (SB, p38 inhibitor) pretreatment inhibited the generation of ROS. On the other hand, N-acetylcysteine (NAC) pretreatment prevented the phosphorylation of p38 but not that of JNK. Taken together, these data reveal that BVC induces HepaRG cell death via ROS and the JNK/p38 signaling pathways.

4 March 2023 in Molecules
Verified
Journal Article
Open access
PDF file
JYJia Yi
Jia Yi
YLYan Li
Yan Li
HSHai Shang
Hai Shang
YLYun Luo
Yun Luo
TYTian Yu
Tian Yu
The mechanisms of action of natural products and the identification of their targets have long been a research hotspot. Ganoderic acid A (GAA) is the earliest and most abundant triterpenoids discovered in Ganoderma lucidum. The multi-therapeutic potential of GAA, in particular its anti-tumor activity, has been extensively studied. However, the unknown targets and associated pathways of GAA, together with its low activity, limit in-depth research compared to other small molecule anti-cancer drugs. In this study, GAA was modified at the carboxyl group to synthesize a series of amide compounds, and the in vitro anti-tumor activities of the derivatives were investigated. Finally, compound A2 was selected to study its mechanism of action because of its high activity in three different types of tumor cell lines and low toxicity to normal cells. The results showed that A2 could induce apoptosis by regulating the p53 signaling pathway and may be involved in inhibiting the interaction of MDM2 and p53 by binding to MDM2 (KD = 1.68 µM). This study provides some inspiration for the research into the anti-tumor targets and mechanisms of GAA and its derivatives, as well as for the discovery of active candidates based on this series.

14 November 2022 in Pharmaceutical Biology
Verified
Journal Article
Open access
XZXuelian Zhang
Xuelian Zhang
DWDaoshun Wu
Daoshun Wu
TYTian Yu
Tian Yu
XCXiangdong Chen
Xiangdong Chen
JLJin Lan
Jin Lan
XSXiaobo Sun
Xiaobo Sun
Ganoderma lucidum polysaccharides (GLP), from Ganoderma lucidum (Leyss. ex Fr.) Karst. (Ganodermataceae), are reported to have anti-inflammatory effects, including anti-neuroinflammation and anti-c...

22 November 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
JYJia Yi
Jia Yi
YLYan Li
Yan Li
XXXu dong Xu
Xu dong Xu
TYTian Yu
Tian Yu
HSHai Shang
Hai Shang
Autotaxin (ATX) is the only enzyme of the ecto-nucleotide pyrophosphatase/phosphodiesterase (ENPP2) family with lysophospholipase D (lysoPLD) activity, which is mainly responsible for the hydrolysis of extracellular lysophosphatidylcholine (LPC) into lysophosphatidic acid (LPA). LPA can induce various responses, such as cell proliferation, migration, and cytokine production, through six G protein-coupled receptors (LPA1-6). This signaling pathway is associated with metabolic and inflammatory disorder, and inhibiting this pathway has a positive effect on the treatment of related diseases, while ATX, as an important role in the production of LPA, has been shown to be associated with the occurrence and metastasis of tumors, fibrosis and cardiovascular diseases. From mimics of ATX natural lipid substrates to the rational design of small molecule inhibitors, ATX inhibitors have made rapid progress in structural diversity and design over the past 20 years, and three drugs, GLPG1690, BBT-877, and BLD-0409, have entered clinical trials. In this paper, we will review the structure of ATX inhibitors from the perspective of the transformation of design ideas, discuss the advantages and disadvantages of each inhibitor type, and put forward prospects for the development of ATX inhibitors in the future.

17 October 2017 in Molecules
Verified
Journal Article
Open access
PDF file
NZNailiang Zhu
Nailiang Zhu
SZSun Zhonghao
Sun Zhonghao
MHMei-Geng Hu
Mei-Geng Hu
TWTong-Yu Wu
Tong-Yu Wu
JYJingquan Yuan
Jingquan Yuan
XXXu dong Xu
Xu dong Xu
One new cassane diterpene possessing an unusual N bridge between C-19 and C-20 named caesalsappanin R (1), as well as another new diterpene caesalsappanin S (2), were isolated from the seeds of Caesalpinia sappanwith methanol extract. Their structures were determined by spectroscopic analysis and examined alongside existing data from prior studies. Their biological activities were profiled by their antiplasmodial activity.